Skip to main content

Advertisement

Table 4 Number of visits in which there are discrepancies in DAS components in patients with moderate/high disease activity that did not receive treatment intensification

From: DAS steered therapy in clinical practice; cross-sectional results from the METEOR database

  DAS > 2.4 and medication not increased
  Total
SJC ≤1 and TJC ≥2, N (%) 201 (19.6) 1028
SJC ≤1 and VASpt ≥20, N (%) 198 (19.3) 1028
SJC ≤1 and ESR ≥28, N (%) 98 (9.5) 1027
VASpt ≥20 mm higher than VASphys N (%) 148 (32.9) 450
VASphys ≥ 20 mm higher than VASpt, N (%) 25 (5.6) 450
  1. *ESR erythrocyte sedimentation rate, VASpt Patient assessment of Global Disease Activity, TJC Tender Joint Count, SJC Swollen Joint Count, VASphys Physician Assessment of Global Disease Activity